Pharmaceuticals
Advent, Baxter in race to acquire Gland Pharma
15 Apr 2016
Valeant Pharmaceuticals hires investment banks to review strategic options
15 Apr 2016
Valeant Pharmaceuticals International Inc, one of the most aggressive acquirers in the global pharmaceuticals industry, is considering selling "non-core assets" to help trim its $30-billion debt pile